Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0016 | 0.0001 | 0.0001 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0047 | 0.0089 | 1 |
Trichomonas vaginalis | protein arginine N-methyltransferase, putative | 0.0312 | 0.0857 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Brugia malayi | hypothetical protein | 0.0312 | 0.0857 | 0.0857 |
Trypanosoma brucei | Protein arginine N-methyltransferase 1 catalytic subunit | 0.0312 | 0.0857 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0312 | 0.0857 | 0.0857 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.002 | 0.0011 | 0.0329 |
Echinococcus granulosus | methyltransferase protein 5 | 0.0312 | 0.0857 | 0.0857 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.004 | 0.0069 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0047 | 0.0089 | 0.1032 |
Leishmania major | trypanothione reductase | 0.0047 | 0.0089 | 0.1032 |
Entamoeba histolytica | arginine N-methyltransferase 1, putative | 0.0312 | 0.0857 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.002 | 0.0011 | 0.0011 |
Schistosoma mansoni | protein arginine n-methyltransferase | 0.3471 | 1 | 1 |
Trichomonas vaginalis | protein arginine N-methyltransferase, putative | 0.0312 | 0.0857 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.002 | 0.0011 | 1 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0147 | 0.0379 | 0.0379 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0107 | 0.0262 | 0.8837 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0147 | 0.0379 | 0.0379 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0107 | 0.0262 | 0.8837 |
Toxoplasma gondii | histone arginine methyltransferase PRMT4/CARM1 | 0.3471 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0011 | 0.0114 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.0088 | 0.0088 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.002 | 0.0011 | 0.0114 |
Trypanosoma brucei | unspecified product | 0.002 | 0.0011 | 0.0114 |
Toxoplasma gondii | bicoid-interacting protein BIN3 | 0.0312 | 0.0857 | 0.0856 |
Trypanosoma cruzi | arginine N-methyltransferase, type III | 0.0312 | 0.0857 | 1 |
Toxoplasma gondii | histone arginine methyltransferase PRMT3 | 0.0312 | 0.0857 | 0.0856 |
Echinococcus multilocularis | histone arginine methyltransferase CARMER | 0.3471 | 1 | 1 |
Loa Loa (eye worm) | Carm1-pending protein | 0.3471 | 1 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0047 | 0.0089 | 0.2985 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.002 | 0.0011 | 0.0114 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0011 | 0.0114 |
Giardia lamblia | DINP protein human, muc B family | 0.002 | 0.0011 | 0.1439 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0147 | 0.0379 | 0.0379 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.0088 | 0.0088 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0043 | 0.0079 | 0.0913 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0.0001 | 0.5 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0107 | 0.0262 | 0.8837 |
Echinococcus multilocularis | dna polymerase eta | 0.002 | 0.0011 | 0.0011 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0043 | 0.0079 | 0.0078 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Echinococcus granulosus | protein arginine N methyltransferase 7 | 0.0312 | 0.0857 | 0.0857 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.002 | 0.0011 | 0.0011 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Plasmodium falciparum | glutathione reductase | 0.0047 | 0.0089 | 1 |
Echinococcus granulosus | histone arginine methyltransferase CARMER | 0.3471 | 1 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0118 | 0.0297 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.0088 | 0.0088 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0107 | 0.0262 | 0.8837 |
Echinococcus multilocularis | protein arginine N methyltransferase 7 | 0.0312 | 0.0857 | 0.0857 |
Loa Loa (eye worm) | hypothetical protein | 0.0312 | 0.0857 | 0.0857 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0046 | 0.0088 | 0.0088 |
Mycobacterium tuberculosis | Probable reductase | 0.0107 | 0.0262 | 0.8837 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0046 | 0.0088 | 0.0088 |
Loa Loa (eye worm) | protein arginine N-methyltransferase | 0.0312 | 0.0857 | 0.0857 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0107 | 0.0262 | 0.8837 |
Trypanosoma cruzi | arginine N-methyltransferase, type I | 0.0312 | 0.0857 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.0088 | 0.0088 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0046 | 0.0088 | 0.0088 |
Brugia malayi | glutathione reductase | 0.0047 | 0.0089 | 0.0089 |
Plasmodium falciparum | thioredoxin reductase | 0.0047 | 0.0089 | 1 |
Treponema pallidum | NADH oxidase | 0.0016 | 0.0001 | 0.5 |
Onchocerca volvulus | 0.3159 | 0.9097 | 1 | |
Loa Loa (eye worm) | acetyltransferase | 0.0147 | 0.0379 | 0.0379 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.002 | 0.0011 | 0.0329 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.002 | 0.0011 | 0.0114 |
Brugia malayi | Thioredoxin reductase | 0.0047 | 0.0089 | 0.0089 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0046 | 0.0088 | 0.0088 |
Toxoplasma gondii | thioredoxin reductase | 0.0047 | 0.0089 | 0.0088 |
Trypanosoma cruzi | arginine N-methyltransferase, putative | 0.0312 | 0.0857 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.002 | 0.0011 | 0.0114 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.002 | 0.0011 | 0.0011 |
Brugia malayi | Protein arginine N-methyltransferase | 0.0312 | 0.0857 | 0.0857 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0047 | 0.0089 | 0.0089 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.004 | 0.0069 | 0.7666 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.002 | 0.0011 | 0.0011 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0043 | 0.0079 | 0.8845 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0118 | 0.0297 | 1 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0046 | 0.0088 | 0.0088 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0016 | 0.0001 | 0.0001 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0043 | 0.0079 | 0.0913 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0143 | 0.0367 | 0.0367 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Plasmodium vivax | glutathione reductase, putative | 0.0047 | 0.0089 | 1 |
Trypanosoma cruzi | arginine N-methyltransferase, putative | 0.0312 | 0.0857 | 1 |
Echinococcus granulosus | dna polymerase eta | 0.002 | 0.0011 | 0.0011 |
Trichomonas vaginalis | protein arginine N-methyltransferase, putative | 0.0312 | 0.0857 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0047 | 0.0089 | 0.0089 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0043 | 0.0079 | 0.0079 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.0011 | 0.0011 |
Mycobacterium ulcerans | DNA polymerase IV | 0.002 | 0.0011 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Trypanosoma cruzi | protein arginine n-methyltransferase 7 | 0.0312 | 0.0857 | 1 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0047 | 0.0089 | 0.0089 |
Trypanosoma brucei | protein arginine n-methyltransferase 7 | 0.0312 | 0.0857 | 1 |
Echinococcus granulosus | dna polymerase kappa | 0.002 | 0.0011 | 0.0011 |
Trypanosoma cruzi | arginine N-methyltransferase, type I | 0.0312 | 0.0857 | 1 |
Leishmania major | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Entamoeba histolytica | arginine N-methyltransferase protein, putative | 0.0312 | 0.0857 | 1 |
Echinococcus multilocularis | dna polymerase kappa | 0.002 | 0.0011 | 0.0011 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0016 | 0.0001 | 0.5 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0043 | 0.0079 | 0.0078 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0047 | 0.0089 | 0.0089 |
Schistosoma mansoni | DNA polymerase eta | 0.002 | 0.0011 | 0.0011 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0016 | 0.0001 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0118 | 0.0297 | 1 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.002 | 0.0011 | 0.0011 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0047 | 0.0089 | 0.1032 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.004 | 0.0069 | 0.0685 |
Entamoeba histolytica | hypothetical protein | 0.0312 | 0.0857 | 1 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.002 | 0.0011 | 0.0011 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0016 | 0.0001 | 0.0001 |
Leishmania major | arginine N-methyltransferase, type III, putative;with=GeneDB:Tb927.7.5490 | 0.0312 | 0.0857 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.002 | 0.0011 | 0.0011 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.002 | 0.0011 | 0.0114 |
Leishmania major | arginine N-methyltransferase, type I | 0.0312 | 0.0857 | 1 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0016 | 0.0001 | 0.0001 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.002 | 0.0011 | 0.0114 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0118 | 0.0297 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.002 | 0.0011 | 0.0114 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.002 | 0.0011 | 0.0114 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (binding) | < 1 % | Percent inhibitionagainst muscarinic acetylcholine receptor M4 from NG108-15 cell line | ChEMBL. | 2153827 |
Activity (binding) | < 1 % | Percent increase in [3H]-myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells | ChEMBL. | 2153827 |
Affinity (binding) | = 31.9 % | Binding affinity at muscarinic acetylcholine receptor M4 from NG108-15 cell line in presence of [3H]-NMS | ChEMBL. | 2153827 |
Affinity (binding) | = 39.1 % | Percent binding affinity at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells in presence of [3H]-NMS | ChEMBL. | 2153827 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.